Trials / Sponsors / Anagram Therapeutics, Inc.
Anagram Therapeutics, Inc.
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Phase 2 Study to Assess the Safety and Efficacy of ANG003 Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF) | Phase 2 | 2026-04-01 |
| Completed | Phase 1 Study to Assess Safety and Efficacy of ANG003 Exocrine Pancreatic Insufficiency | Phase 1 | 2023-08-25 |